Close Menu

NEW YORK (GenomeWeb) – Premaitha Health said today that it has settled its patent dispute and signed a licensing and supply agreement with Illumina related to noninvasive prenatal testing technology.

Under the agreement, Manchester, UK-based Premaitha has licensed Illumina's NIPT patent pool, allowing it to offer testing in Europe and other countries covered by the intellectual property.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.